Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content

Abstract

Self-imposed limitations due to a fear of discrimination may be just as devastating to persons with first-episode psychosis as the outright discrimination experienced in relationships or employment. In this study, 97 persons with first-episode psychosis and a mean age of 34 were asked about experiences with actual and anticipated discrimination. Many reported having curtailed everyday activities to avoid discrimination, thereby limiting access to opportunities and community resources typically available to younger people. Is discrimination a second illness? the authors asked.

Abstract

Objective

This study aimed to describe patterns of experienced and anticipated discrimination in a sample of persons experiencing a first episode of psychosis and to explore associations with clinical and psychosocial variables.

Methods

This cross-sectional survey was conducted within the context of the Psychosis Incident Cohort Outcome Study, a multisite naturalistic study examining first-episode patients treated in public psychiatric services in the Veneto Region of Italy. The Discrimination and Stigma Scale was used to assess experienced and anticipated discrimination.

Results

Ninety-seven patients were interviewed. Experiences of discrimination were common in relationships with family members (43%), making friends (32%), relationships with neighbors (25%), keeping a job (25%), finding a job (24%), and intimate relationships (23%). In regard to anticipated discrimination, 37% had stopped seeking a close relationship and 34% had stopped looking for work, 58% felt the need to conceal their diagnosis, and 37% reported that other people avoided them. In regression analysis, a higher number of functioning needs together with higher anticipated discrimination were associated with a higher level of experienced discrimination. A higher level of experienced discrimination and greater illness awareness were associated with more anticipated discrimination.

Conclusions

First-episode patients reported experiencing discrimination in several key life areas. Anticipated discrimination further limited their access to life opportunities. Patients’ awareness of the negative consequences of symptoms and disabilities led them to more easily perceive discrimination.
The first psychotic episode represents a challenging period for patients and families. Patients frequently feel overwhelmed with hopelessness, fear, guilt, and shame (1,2). They must cope not only with their new clinical condition but also with the stigma they encounter in everyday life as a result of their psychiatric diagnosis (3). Stigma can be seen as an overarching concept that includes problems of knowledge (ignorance or misinformation), attitudes (prejudice), and behavior (discrimination) (4). Discrimination against persons with mental health problems has important ethical, political, and clinical implications (57).
Research on discrimination in regard to mental disorders has mainly focused on attitudes and emotions in the general population and professionals toward patients (814). Only recently has research begun to explore patients' self-reported experiences of discrimination; all of the more recent studies have examined patients with long-standing psychiatric conditions (2,7,1520). To the best of our knowledge, no study has specifically addressed the ways in which discrimination (that is, the behavioral component of stigma) affects the lives of persons experiencing a first episode of psychosis. This research gap represents a major drawback, because this is a specific population with well-defined characteristics. In fact, the literature reports a substantial difference between the clinical and social needs of this group and those of patients with illnesses of longer duration. The former are generally young, living with their families, attending educational or training systems, and seeking to enter the labor market (21,22). Patients experiencing a first episode of psychosis may therefore report more discrimination in life domains pertaining to young people’s social world (such as training or education, friendship, and family relations), but empirical data are lacking.
In addition, research indicates that reported discrimination levels tend to increase as the illness progresses; specifically, time from first mental health service contact has been found to be associated with a higher level of experienced discrimination (7,19). This finding suggests that patients experiencing a first episode of psychosis may be less exposed than patients with chronic illness to the pernicious effects of discrimination and may therefore experience less discrimination. The assumption, however, has not yet been verified with a sample of persons experiencing a first episode of psychosis.
Moreover, the first psychotic episode is a complex period characterized by the occurrence of extremely severe symptoms, which are frequently associated with an insidious functional decline that dramatically disrupts the patient’s quality of life and community integration (23). Associations between symptoms, social functioning, and discrimination merit greater empirical focus, because research has shown that greater perceived social discrimination among those with longer-term mental disorders is significantly associated with more severe symptoms (16) and more functional impairment (24,25). This association, however, has not yet been tested among patients experiencing a first episode of psychosis.
In an effort to bridge these knowledge gaps, this study examined a sample of patients experiencing a first episode of psychosis with the specific aim of investigating experienced and anticipated discrimination patterns and their associations with sociodemographic and clinical variables. Experienced discrimination refers to an individual's perception that he or she has been treated unfairly by others because of a mental health condition. Anticipated discrimination occurs when a person limits involvement in important aspects of everyday life because of the fear of being discriminated against.
We addressed the following hypotheses. First, given that the needs of people experiencing a first episode of psychosis differ substantially from those with longer-standing illness, first-episode patients were expected to report more discrimination in life domains specifically pertaining to young people’s social world (for example, training or education, friendship, and family relations). Second, given that time from first contact with mental health services was found to be associated with higher levels of experienced discrimination, first-episode patients were expected to report, on average, lower levels of experienced discrimination than patients with chronic psychosis. Third, higher levels of perceived discrimination were expected to be associated with more severe symptoms and poorer social functioning, as assessed by both clinician-rated and patient-rated measures. To address the first two hypotheses, data from people with long-standing psychosis recruited in Italy for the INDIGO (INternational study of DIscrimination and stiGma Outcomes) schizophrenia study were also used (7,19).

Methods

Study design

This cross-sectional study was conducted within the framework of the Psychosis Incident Cohort Outcome Study (PICOS), a multisite collaborative study that examined the relative roles of clinical, social, genetic, and morpho-functional factors in predicting outcomes among patients experiencing a first episode of psychosis who were in contact with public mental health services in the Veneto Region, northeast Italy (22,26). This study assessed experiences of discrimination in a sample of first-episode patients recruited from a subset of sites (30%) participating in PICOS; sites were selected on the basis of availability of local resources to perform these evaluations.

Geographical and care context

The Veneto Region has a population of 4.6 million. Most residents are Caucasian, and 10% are immigrants. The urban structure is polycentric, with a few large-scale cities (>200,000 inhabitants) and many mid- and smaller-scale cities.
Psychiatric care is delivered by the Italian National Health Service through its Departments of Mental Health (DMHs), which are responsible for the provision of comprehensive and integrated care to the adult population living in a geographically defined catchment area of approximately 250,000–300,000 inhabitants. Multidisciplinary teams operating the DMHs provide a wide range of programs, including inpatient care, day care, rehabilitation, outpatient care, home visits, 24-hour emergency services, and residential treatment for long-term patients.

Participants

The target group for PICOS was individuals aged 15–54 years who were residents in the Veneto Region and had first contact with any mental health service from January 2005 to December 2007, with evidence of the following: delusions, hallucinations, thought disorder, or negative symptoms of psychosis, irrespective of cause (26). The primary exclusion criterion was any previous presentation or treatment for psychotic illness, other than initiation of treatment for the current episode during the previous three months. Written informed consent was obtained from participants. The study was approved by the ethics committees of the coordinating center (Azienda Ospedaliera di Verona) and the local sites.

Measures

Discrimination was assessed by researchers who were not involved in the care process, using the Discrimination and Stigma Scale (DISC-10) (7), which has good psychometric properties (27). In a face-to-face interview, DISC-10 respondents are asked to comment on various key areas of everyday life and social participation. The first section collects sociodemographic information. The second section evaluates experienced discrimination (for example, “Have you been treated differently from other people in making or keeping friends because of your mental illness diagnosis?”). Items are scored on a 4-point Likert scale (0, no difference; 1, slight disadvantage; 2, moderate disadvantage; and 3, strong disadvantage). The third section explores anticipated discrimination—that is, the extent to which respondents limit their own involvement in important aspects of everyday life (for example, “How much have you stopped yourself from applying for work or for training/education because of your mental illness diagnosis?”). Items are scored on a 4-point Likert scale (0, not at all; 1, a little; 2, moderately; and 3, a lot); respondents who agree with anticipated discrimination items indicate that they not only anticipate discrimination but avoid activities and give up life goals as a consequence. Two subscores (experienced discrimination and anticipated discrimination) were generated by counting the number of items in which participants reported a disadvantage (that is, scores of 1–3).
Symptoms were assessed by the Positive and Negative Syndrome Scale (PANSS) (28). Patients’ symptom attribution and awareness of illness were assessed by the Schedule for Assessment of Insight (SAI-E) (29). Clinician-rated social functioning was assessed by the Disability Assessment Schedule (DAS) (30), and patient-rated social functioning was assessed by the Camberwell Assessment of Need (CAN) (31), the Manchester Short Assessment scale (MANSA) (32), and the Verona Service Satisfaction Scale (VSSS) (33). An interrater reliability session yielded an interrater reliability of .90 for the PANSS (Cohen’s kappa).

Statistical analyses

Analyses were performed by SPSS, version 17.0. All p values were two-tailed with a significance level of .05. Nonnormality of continuous variables was checked, and nonparametric tests were chosen. Comparisons were performed by chi square and Mann-Whitney tests. Correlations were explored by Spearman’s rho coefficient. A multivariate negative binomial regression model (‘nbreg’ Stata command) was estimated with the experienced discrimination subscore as the dependent variable, and a set of potential explanatory variables was specifically selected to address the third study hypothesis: age, anticipated discrimination, gender, nationality, compulsory treatment, education, employment, marital status, diagnosis, and scores on the PANSS, DAS, CAN, SAI-E, VSSS, and MANSA. The same strategy was applied for the anticipated discrimination subscore. All models were performed by the cluster option, which specifies that the observations are independent across groups but not necessarily independent within groups.

Results

A total of 97 patients experiencing a first episode of psychosis were assessed with the DISC-10. Table 1 summarizes data on the sample’s characteristics. Table 2 presents the overall profile of experienced discrimination, with responses reporting any disadvantage combined. The most common areas of experienced discrimination (>20%) were relationships with family members, making or keeping friends, keeping a job, relationships with neighbors, finding a job, and dating or intimate relationships. Table 2 also presents results for anticipated discrimination. A large proportion of patients (approximately 60%) felt the need to conceal their diagnosis. The most frequent areas for anticipated discrimination (>30%) were being avoided by other people and stopping oneself from having close personal relationships and from applying for work, education, or training.
Table 1 Characteristics of 97 patients with first-episode psychosis
CharacteristicN%
Age (M±SD)34.11±9.07 
Male5557
Educational level  
 Low (<16 years)4747
 High (≥16 years)5053
Living arrangementa  
 Alone910
 With partner or children2729
 With relative or in structured arrangement5761
Marital statusb  
 Married2226
 Single5766
 Separated or divorced78
Working conditionc  
 Full- or part-time5766
 Student1011
 Unemployed2830
Nationality  
 Italian8386
 Other1414
Diagnosis  
 Affective psychosis1819
 Nonaffective psychosis7981
Current mental health cared  
 Outpatient8795
 Inpatient33
 Home or day care22
Compulsory admission (lifetime)e2021
a
Data missing for 4 participants
b
Data missing for 11 participants
c
Data missing for 2 participants
d
Data missing for 5 participants
e
Data missing for 2 participants
Table 2 Responses to DISC-10 items by 97 patients experiencing a first episode of psychosisa
Type of discrimination and itemYesbNoNot applicable
N%N%N%
Experienced discrimination      
 Family relationshipsc4243515333
 Making or keeping friends3132616355
 Keeping a job242542433132
 Relationships with neighbors2425656788
 Finding a job232433344142
 Dating or intimate relationshipsc222352542223
 Social life171858602223
 Role as a parentc131317186668
 Levels of privacyc1212757799
 Housing101025266264
 Starting a family or having childrenc101020216668
 Welfare benefitsc9922236567
 Health care7762642829
 Education7725266567
 Religious practicesc7750523940
 Public transportc5570722122
 Policed5546474445
 Marriage or divorcec5519207274
 Personal safety and securityd4468702324
Anticipated discrimination      
 Concealed diagnosisc565828291212
 Avoided or shunned by other people3637596122
 Close personal relationshipd363747491212
 Apply for work, education or training33344546.41920
 Humiliated by other people1313798155
a
DISC-10, Discrimination and Stigma Scale
b
For experienced discrimination, values represent patients scoring 1–3 (slight, moderate, or strong disadvantage). For anticipated discrimination, values represent patients scoring 1–3 (a little, moderately, or a lot).
c
Data missing for 1 participant
d
Data missing for 2 participants
Figure 1 illustrates how experienced discrimination reported by these first-episode patients compares with that reported by patients with long-standing schizophrenia who were recruited in the Italian INDIGO sites (19) and those who were recruited across all INDIGO sites (7). Figure 2 compares anticipated discrimination for these groups.
Figure 1 Patients reporting experiences of discrimination in the PICOS sample with first-episode psychosis and in two INDIGO samples with chronic schizophreniaa
a PICOS, Psychosis Incident Cohort Outcome Study; INDIGO, INternational study of DIscrimination and stiGma Outcomes (Italian sites [7] and all INDIGO sites [19])
Figure 2 Patients reporting anticipated discrimination in the PICOS sample with first-episode psychosis and in two INDIGO samples with chronic schizophreniaa
a PICOS, Psychosis Incident Cohort Outcome Study; INDIGO, INternational study of DIscrimination and stiGma Outcomes (Italian sites [7] and all INDIGO sites [19])
The multivariate model showed that patients who reported higher levels of experienced discrimination (Table 3) also reported greater anticipated discrimination, a lower level of education, a higher level of met needs in the functioning domain (that is, self-care, looking after the home, child care, money, and education), and a poorer subjective quality of life in the family domain. It should be noted that met needs represent an index of service provision, because according to the CAN, a need is considered to be met when patients report that there is no problem in a specific domain because of the help provided (but that a problem would exist if no help were provided). Patients reporting higher levels of anticipated discrimination (Table 3) had higher levels of experienced discrimination and greater illness insight.
Table 3 Negative binomial regression models for experienced and anticipated discrimination among 97 patients experiencing a first episode of psychosisa
Independent variablebCoefficient95% CIp
Experienced discrimination   
 Education (reference: high level)–.786–1.253 to –.320.001
 PANSS, conceptual disorganization.254–.043 to .550.093
 PANSS, tension.028–.175 to .231.784
 CAN, met needs for health.010–.165 to .186.908
 CAN, met needs for functioning.281.003 to .562.049
 VSSS, skills and behavior of professionals–.290–.796 to .217.263
 MANSA, satisfaction with family relations–.232–.391to –.073.004
 Anticipated discrimination.284.124 to .444.001
Anticipated discrimination   
 Age–.009–.023 to .007.235
 PANSS, tension.051–.053 to .154.335
 VSSS, overall satisfaction–.082–.301 to .137.462
 VSSS, accessibility of services–.082–.261 to .096.366
 SAI-E subscore.017.003 to .042.040
 Experienced discrimination.036.007 to .066.016
a
Only independent variables significant at p<.05 are shown (p is adjusted for clustering).
b
PANSS, Positive and Negative Syndrome Scale; CAN, Camberwell Assessment of Need; VSSS, Verona Service Satisfaction Scale; MANSA, Manchester Short Assessment scale; SAI-E, Schedule for Assessment of Insight

Discussion

This study is the first to explore reported experiences of discrimination among persons experiencing a first episode of psychosis. The use of interviews to gather direct self-reports from these individuals in regard to both anticipated and experienced discrimination (compared with the use of hypothetical scenarios or vignettes) represents a methodological strength of this study. In fact, most research on discrimination against persons with mental health conditions has been largely descriptive and based on surveys of public attitudes toward hypothetical (versus real) situations. The research has therefore mostly explored what “normal” people might say about psychotic patients, rather than the ways in which discrimination is experienced by people who have a mental illness. Indeed, we propose that gathering patient reports on their own experiences of discrimination may serve the further purpose of empowering them by giving them a voice and acknowledging the validity of their experiences.
Our main finding was that depending on the form of discrimination, approximately one-half to one-third of first-episode patients reported having experienced discrimination in their everyday lives. Experienced discrimination mainly affects life domains that pertain to an individual’s basic requirements for achieving full social integration, such as family, friendship, employment, and intimate relationships. Moreover, anticipated discrimination was also common. Up to 37% of individuals in the sample were affected by some form of anticipated discrimination, further limiting these patients’ access to a number of important life opportunities (such as making or keeping friends and seeking close relationships) and community resources. Anticipated discrimination could lead patients quite early in their illness trajectory to give up on the idea of being able to benefit from opportunities and from participating in everyday life activities, which would negatively affect social outcomes and individually defined life goals (the so-called why try effect) (34).
Furthermore, we found that most of the surveyed patients actively concealed their condition from others. Such concealment is a major treatment issue, because nondisclosure of a mental health condition can interfere with help-seeking behavior, creating a major obstacle to receiving effective treatment. Some patients may avoid treatment out of fear of being judged or discriminated against. Others may avoid dealing with issues related to their mental health condition because doing so could have a negative impact on their self-esteem, which may already be compromised. Concealment also has general negative effects, such as reduced self-esteem, increased psychological distress, impaired interpersonal relations, and reduced relatedness to key institutions such as work (35), whereas disclosure or coming out about one’s mental illness may have positive effects (36).
Regarding our first hypothesis, we expected that compared with patients with chronic schizophrenia, first-episode patients would report higher discrimination in life domains specifically pertaining to young people’s social world (such as training or education, friendship, and family relationships). This pattern was expected, given that the needs of people experiencing a first episode of psychosis—who are generally young, living with their families, attending educational or training systems, and seeking to enter the labor market—substantially differ from those of individuals with an illness of longer duration (21,22). This hypothesis was not confirmed because we found that the main sources of discrimination reported by first-episode patients (family, friendship, and job) substantially overlap with those observed among people with chronic schizophrenia (7,19) (Figure 1). This finding suggests that interpersonal relations (either with family members or with people outside the family) and employment are frequently problematic domains for patients with psychosis in general, regardless of their illness phase. Patients must deal with these difficulties at a very early stage of their illness, and these problems tend to remain unsolved.
The picture differs for anticipated discrimination, because a phase-specific pattern was observed. Whereas most first-episode patients reported problems in keeping or making friends and establishing intimate relationships, job domain was the most problematic area for patients with chronic schizophrenia (7,19) (Figure 2). The key role of relationships for young people versus the work-related and financial problems that commonly affect middle-aged individuals might account for this difference. In addition, the degree of demoralization implied in the DISC-10’s construct of anticipated discrimination may not yet be as high among first-episode patients.
Second, we hypothesized that first-episode patients would report, on average, lower levels of experienced discrimination compared with patients with chronic schizophrenia, because research has found that experienced discrimination is associated with time from first mental health service contact (7). However, the percentages reporting discrimination were substantially similar among first-episode patients and those with chronic illness; slightly larger proportions of the latter group reported discrimination in areas such as finding and keeping a job, whereas the proportions of first-episode patients reporting discrimination in the social life domain were considerably higher than among those with chronic illness (Figure 1).
Finally, we hypothesized that higher levels of discrimination would be associated with more severe psychotic symptoms and poorer social functioning (16,24,25). This hypothesis was partially confirmed. We found that discrimination was not associated with levels of psychopathology and that higher levels of discrimination were associated with poorer self-perceived social functioning. In fact, patients who reported higher levels of discrimination reported higher levels of need in the functioning domain (self-care, looking after the home, child care, money, and education) and poorer life satisfaction with family relationships. This finding provides further support for the idea that anticipated discrimination acts as a barrier for people with mental disorders in achieving full integration into their social networks. It also suggests that the process leading to social exclusion can occur in various illness phases—in the beginning and in the longer term.
It should also be noted that patients with a higher level of insight into their illness reported greater levels of anticipated discrimination. Thus illness insight appears to play a role in mediating patients’ clinical condition and appraisals of their social environment (37,38). A number of studies have reported that awareness of having a mental disorder is a “double-edged sword” for patients with psychosis. Poor insight is linked to poorer treatment adherence, poorer clinical outcome, poorer social functioning, greater vocational dysfunction, and difficulties in developing working relationships with mental health professionals (39). On the other hand, greater insight has been associated with higher levels of dysphoria, lower self-esteem, and diminished well-being and quality of life (4042). Thus patients’ greater awareness of the negative consequences of their psychosis-related symptoms and disabilities can lead them to more easily recognize the discrimination that exists in society toward individuals with mental health problems and, possibly, toward themselves.
Acceptance of having a severe mental disorder, however, depends on the meanings a person attaches to his or her diagnosis (24). Greater awareness of illness could lead to hopelessness and self-devaluation; understanding that one has a psychotic disorder may lead to a belief that one is not capable of achieving valued social roles. Therefore, mental health professionals should pursue all efforts to empower patients to take an active role in their everyday life and in treatment decisions. Some promising interventions, such as narrative enhancement and cognitive therapy (43), specifically target self-stigma. Insight into mental illness with a personal and nonstigmatized interpretation may allow people with severe mental health problems to use insight as a beneficial factor in their recovery process (44).
This study also had several limitations. First, given its cross-sectional design, no conclusions can be drawn regarding causality, and alternative explanations for the findings cannot be ruled out. Second, no information was available on labeling experiences of participants (that is, when and in what contexts participants were labeled as “mentally ill” or “psychotic”). Third, the relatively small sample limits the generalizability of the findings. Fourth, no control or comparison group was used, which prevents our sample of first-episode patients from being compared directly with other groups. Fifth, because the sample surveyed was a convenience sample, selection bias might also have occurred, further limiting the generalizability of findings. Sixth, generalizability may also be limited by the fact that participants were recruited from the mental health system, and they may have been more likely to have had positive attitudes toward help seeking, more illness insight, and more labeling experiences as a result of their mental health service use.

Conclusions

People with psychosis report experiences of discrimination in a number of important life areas from the beginning of their illness. Discrimination should be considered a “second illness,” because it further limits patients’ life opportunities. Greater awareness of the negative consequences of symptoms and disabilities linked to their psychiatric condition led first-episode patients to more easily perceive discrimination in their environment. These findings suggest the need for mental health services to develop timely and specific strategies to enhance patients’ self-esteem and promote full social integration as early in the illness course as possible. Further research on stigma and discrimination among persons experiencing a first episode of psychosis is needed, and studies with larger samples conducted in different geographical areas are warranted. Moreover, an important step forward for future research would be to compare levels of stigma and discrimination reported by people experiencing a first episode of psychosis and those at risk of psychosis.

Acknowledgments and disclosures

This study was supported by a grant to Prof. Ruggeri from the Ricerca Sanitaria Finalizzata 2004, Giunta Regionale del Veneto; by a grant to Dr. Lasalvia from the Ricerca Sanitaria Finalizzata 2005, Giunta Regionale del Veneto; and by a three-year grant from the Fondazione Cariverona to Prof. Tansella and the World Health Organization Collaborating Centre for Research and Training in Mental Health and Service Organization at the University of Verona. The authors acknowledge the members of the PICOS-VENETO group, whose names are listed in an online supplement to this article.
The authors report no competing interests.

Supplementary Material

Supplementary Material (1034_ds001.pdf)

References

1.
de Haan L, Peters B, Dingemans P, et al.: Attitudes of patients toward the first psychotic episode and the start of treatment. Schizophrenia Bulletin 28:431–442, 2002
2.
Miller R, Mason SE: Shame and guilt in first episode schizophrenia and schizoaffective disorders. Journal of Contemporary Psychotherapy 35:211–221, 2005
3.
Schulze B, Angermeyer MC: Subjective experiences of stigma: a focus group study of schizophrenic patients, their relatives and mental health professionals. Social Science and Medicine 56:299–312, 2003
4.
Thornicroft G, Rose D, Kassam A, et al.: Stigma: ignorance, prejudice or discrimination? British Journal of Psychiatry 190:192–193, 2007
5.
Oliver MI, Pearson N, Coe N, et al.: Help-seeking behaviour in men and women with common mental health problems: cross-sectional study. British Journal of Psychiatry 186:297–301, 2005
6.
Link BG, Struening EL, Rahav M, et al.: On stigma and its consequences: evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. Journal of Health and Social Behavior 38:177–190, 1997
7.
Thornicroft G, Brohan E, Rose D, et al.: Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet 373:408–415, 2009
8.
Jorm AF, Korten AE, Jacomb PA, et al.: Attitudes towards people with a mental disorder: a survey of the Australian public and health professionals. Australian and New Zealand Journal of Psychiatry 33:77–83, 1999
9.
Crisp AH, Gelder MG, Rix S, et al.: Stigmatisation of people with mental illnesses. British Journal of Psychiatry 177:4–7, 2000
10.
Stuart H, Arboleda-Flórez J: Community attitudes toward people with schizophrenia. Canadian Journal of Psychiatry 46:245–252, 2001
11.
Gaebel W, Baumann A, Witte AM, et al.: Public attitudes towards people with mental illness in six German cities: results of a public survey under special consideration of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 252:278–287, 2002
12.
Lauber C, Nordt C, Falcato L, et al.: Factors influencing social distance toward people with mental illness. Community Mental Health Journal 40:265–274, 2004
13.
Angermeyer MC, Holzinger A, Matschinger H: Emotional reactions to people with mental illness. Epidemiologia e Psichiatria Sociale 19:26–32, 2010
14.
Holzinger A, Floris F, Schomerus G, et al.: Gender differences in public beliefs and attitudes about mental disorder in western countries: a systematic review of population studies. Epidemiology and Psychiatric Science 21:73–85, 2012
15.
Dickerson FB, Sommerville J, Origoni AE, et al.: Experiences of stigma among outpatients with schizophrenia. Schizophrenia Bulletin 28:143–155, 2002
16.
Ertugrul A, Uluğ B: Perception of stigma among patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology 39:73–77, 2004
17.
Mueller B, Nordt C, Lauber C, et al.: Social support modifies perceived stigmatization in the first years of mental illness: a longitudinal approach. Social Science and Medicine 62:39–49, 2006
18.
Yanos PT, Roe D, Markus K, et al.: Pathways between internalized stigma and outcomes related to recovery in schizophrenia spectrum disorders. Psychiatric Services 59:1437–1442, 2008
19.
Maggiolo D, Buizza C, Vittorielli M, et al.: Patterns of experienced and anticipated discrimination in patients with schizophremia: Italian results from the INDIGO international multisite project [in Italian]. Epidemiologia e Psichiatria Sociale 19:314–325, 2010
20.
Lam MM, Pearson V, Ng RM, et al.: What does recovery from psychosis mean? Perceptions of young first-episode patients. International Journal of Social Psychiatry 57:580–587, 2011
21.
Malla AM, Norman RM: Treating psychosis: is there more to early intervention than intervening early? Canadian Journal of Psychiatry 46:645–648, 2001
22.
Bertani M, Lasalvia A, Bonetto C, et al.: The influence of gender on clinical and social characteristics of patients at psychosis onset: a report from the Psychosis Incident Cohort Outcome Study (PICOS). Psychological Medicine 42:769–780, 2012
23.
Malla A, Payne J: First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophrenia Bulletin 31:650–671, 2005
24.
Lysaker PH, Davis LW, Warman DM, et al.: Stigma, social function and symptoms in schizophrenia and schizoaffective disorder: associations across 6 months. Psychiatry Research 149:89–95, 2007
25.
Vázquez GH, Kapczinski F, Magalhaes PV, et al.: Stigma and functioning in patients with bipolar disorder. Journal of Affective Disorders 130:323–327, 2011
26.
Lasalvia A, Tosato S, Brambilla P, et al.: Psychosis Incident Cohort Outcome Study (PICOS): a multisite study of clinical, social and biological characteristics, patterns of care and predictors of outcome in first-episode psychosis—background, methodology and overview of the patient sample. Epidemiology and Psychiatric Sciences 21:281–303, 2012
27.
Brohan E, Clement S, Rose D, et al.: Development and psychometric evaluation of the Discrimination and Stigma Scale (DISC). Psychiatry Research 208:33–40, 2013
28.
Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13:261–276, 1987
29.
Kemp R, David A: Insight and compliance; in Treatment Compliance and the Therapeutic Alliance. Edited by, Blackwell B. Amsterdam, Harwood Academic Publishers, 1996
30.
WHO Psychiatric Disability Assessment Schedule. Geneva, World Health Organization, 1988
31.
McCrone P, Leese M, Thornicroft G, et al.: Reliability of the Camberwell Assessment of Need–European Version: EPSILON Study 6. European psychiatric services: inputs linked to outcome domains and needs. British Journal of Psychiatry 177(suppl 39):s34–s40, 2000
32.
Priebe S, Huxley P, Knight S, et al.: Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry 45:7–12, 1999
33.
Ruggeri M, Lasalvia A, Dall’Agnola R, et al.: Development, internal consistency and reliability of the Verona Service Satisfaction Scale–European Version. EPSILON Study 7. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. British Journal of Psychiatry 177(suppl 39):s41–s48, 2000
34.
Corrigan PW, Larson JE, Rüsch N: Self-stigma and the “why try” effect: impact on life goals and evidence-based practices. World Psychiatry 8:75–81, 2009
35.
Pachankis JE: The psychological implications of concealing a stigma: a cognitive-affective-behavioral model. Psychological Bulletin 133:328–345, 2007
36.
Corrigan PW, Kosyluk KA, Rüsch N: Reducing self-stigma by coming out proud. American Journal of Public Health 103:794–800, 2013
37.
Lysaker PH, Campbell K, Johannesen JK: Hope, awareness of illness, and coping in schizophrenia spectrum disorders: evidence of an interaction. Journal of Nervous and Mental Disease 193:287–292, 2005
38.
Staring AB, Van der Gaag M, Van den Berge M, et al.: Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders. Schizophrenia Research 115:363–369, 2009
39.
Morgan KD, David AS: Awareness is not the same as acceptance: exploring the thinking behind insight and acceptance; in Metacognition and Severe Adult Mental Disorders: From Research to Treatment. Edited by, Dimaggio G, Lysaker PH. New York, Routledge, 2010
40.
Drake RE, Cotton PG: Depression, hopelessness and suicide in chronic schizophrenia. British Journal of Psychiatry 148:554–559, 1986
41.
Kim CH, Jayathilake K, Meltzer HY: Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophrenia Research 60:71–80, 2003
42.
Mintz AR, Dobson KS, Romney DM: Insight in schizophrenia: a meta-analysis. Schizophrenia Research 61:75–88, 2003
43.
Yanos PT, Roe D, Lysaker PH: Narrative enhancement and cognitive therapy: a new group-based treatment for internalized stigma among persons with severe mental illness. International Journal of Group Psychotherapy 61:577–595, 2011
44.
Roe D, Hasson-Ohayon I, Mashiach-Eizenberg M, et al.: Narrative Enhancement and Cognitive Therapy (NECT) effectiveness: a quasi-experimental study. Journal of Clinical Psychology (Epub ahead of print, Oct 2, 2013)

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Deep Cove Lobster Man, by N. C. Wyeth, ca. 1938. Oil on gessoed board (renaissance panel). Accession number 1939.16. Courtesy of the Pennsylvania Academy of Fine Arts, Philadelphia, Joseph E. Temple Fund.

Psychiatric Services
Pages: 1034 - 1040
PubMed: 24788167

History

Published in print: August 2014
Published online: 15 October 2014

Authors

Details

Antonio Lasalvia, M.D., Ph.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Silvia Zoppei, D.Clin.Psy.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Chiara Bonetto, Ph.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Sarah Tosato, M.D., Ph.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Gioia Zanatta, D.Clin.Psy.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Doriana Cristofalo, Edu.Sci.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Katia De Santi, M.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Mariaelena Bertani, Ph.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Sarah Bissoli, Ph.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Lorenza Lazzarotto, D.Clin.Psy.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Enrico Ceccato, D.Clin.Psy.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Rossana Riolo, M.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Vanna Marangon, M.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Carla Cremonese, M.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Ileana Boggian, D.Clin.Psy.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Michele Tansella, M.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.
Mirella Ruggeri, M.D., Ph.D.
Dr. Lasalvia, Dr. Zoppei, Dr. Bonetto, Dr. Tosato, Dr. Zanatta, Dr. Cristofalo, Dr. De Santi, Dr. Bertani, Dr. Bissoli, Dr. Lazzarotto, Prof. Tansella, and Prof. Ruggeri are with the Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy (e-mail: [email protected]). Dr. Ceccato is with the Department of Mental Health, Local Health Authority, Montecchio, Italy. Dr. Riolo is with the Department of Mental Health, Local Health Authority, Camposampiero, Italy. Dr. Marangon is with the Department of Mental Health, Local Health Authority, Mirano, Italy. Dr. Cremonese is with the Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy. Dr. Boggian is with the Department of Mental Health, Local Health Authority, Legnago, Italy.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share